The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Coding Corner Answer: Trigger Point Injections for Fibromyalgia

Rheumatology Coding Corner Answer: Trigger Point Injections for Fibromyalgia

June 15, 2015 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Take the challenge.

You Might Also Like
  • Rheumatology Coding Corner Answer: Billing for Trigger Point Injection, Office Visit
  • Rheumatology Coding Corner Question: Trigger-Point Injections for Fibromyalgia
  • Coding Corner Answer: November Coding Challenge
Explore This Issue
June 2015
Also By This Author
  • Rheumatologists Share Research, Successes at Annual Investigators’ Meeting

CPT codes: 99213-25, 20553, 73120/LT
Diagnosis: ICD-9 7291
ICD-10 M79.7

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Coding for trigger-point injections continues to create a lot of confusion on proper coding guidelines. Keep in mind, two CPT4 codes can be used for trigger-point procedures:

  • 20552—Injection(s); single or multiple trigger point(s), one or two muscle(s); and
  • 20553—Single or multiple trigger point(s), three or more muscles.

The CPT4 codes are based on the number of muscles affected, not the number of injections given to the patient. Billing for the number of injections given and not by the number of muscles injected is a common mistake.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Also, the E/M service is allowed for this office visit and should be billed with the modifier -25, since the decision to give the injections was made after the examination.

This encounter is coded as 99213 because it included:

  • History—Expanded problem focused: history of present illness was brief, the review of system was extended and the past family medical history was not documented.
  • Examination—Expanded problem focused: it was stated in the example.
  • Medical decision making—Low complexity: the number of problems was limited (established problem worsening), amount of data was minimal for the X-ray and the level of risk was moderate because of one or more chronic illnesses with mild exacerbation, progression or side effect to treatment.

A level-three E/M visit is acceptable because the history was expanded problem focused, the examination was expanded problem focused and the medical decision making complexity was moderate. An established patient visit only needs two out of the three elements—history, examination and medical decision making—to determine the level of a visit.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Additionally, if an office performs diagnostic imaging, the procedure should be billed as a global service, which includes the imaging and interpretation.

The ICD-10 code M79.7 is for fibromyalgia; it is one of the few codes that crosswalks as a one-to-one match from ICD-9 to ICD-10.

For more information on coding, billing or ICD-10 training, contact Melesia Tillman, CPC, CPC-I, CRHC, CHA at [email protected] or 404-633-3777 x820.

Filed Under: Billing/Coding, From the College, Practice Management Tagged With: Billing, Coding, Fibromyalgia, patient care, rheumatologist, trigger-point injectionIssue: June 2015

You Might Also Like:
  • Rheumatology Coding Corner Answer: Billing for Trigger Point Injection, Office Visit
  • Rheumatology Coding Corner Question: Trigger-Point Injections for Fibromyalgia
  • Coding Corner Answer: November Coding Challenge
  • Coding Corner Answer

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)